Back to search
FDAFDA · Food and drugs·Recall number D-1741-2019

CRYO-273 Cold Pain Relieving Gel 128 FL. OZ. Distributed By: CRYO-273.com Tampa, FL 33629. UPC 8 15290 01550 2

Published August 21, 2019 · Recall initiated: July 11, 2019

Summary

FDA records drug Class II recall D-1741-2019, published August 21, 2019 and initiated July 11, 2019. Recalling firm: US Pharmaceuticals Inc.; Status: Terminated; Reported quantity: 314 cases; Lot: Lot #'s 13K17 EXP 08/2019, 03L17 EXP 09/2019, 74H18 EXP 06/2020, 18J18 EXP 06/2020. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

CGMP Deviations: Out of Specification results for either total microbial count or total organic carbon in the purified water utilized in the manufacturing process.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
US Pharmaceuticals Inc.
Distributor
Distributed Nationwide in the USA
Lot
Lot #'s 13K17 EXP 08/2019, 03L17 EXP 09/2019, 74H18 EXP 06/2020, 18J18 EXP 06/2020
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was CRYO-273 Cold Pain Relieving Gel 128 FL. OZ. Distributed By: CRYO-273.com Tampa, FL 33629. UPC 8 15290 01550 2 recalled?

Yes. FDA published recall D-1741-2019 on August 21, 2019. Reported hazard: CGMP Deviations: Out of Specification results for either total microbial count or total organic carbon in the purified water utilized in the manufacturing process.

What should I do if I have this product?

Voluntary: Firm initiated · Letter